Glutamate and monoamine transporters: new visions of form and function
- PMID: 17509873
- DOI: 10.1016/j.conb.2007.05.002
Glutamate and monoamine transporters: new visions of form and function
Abstract
Neurotransmitters are rapidly removed from the extracellular space primarily through the actions of plasma membrane transporters. This uptake process is not only essential in the termination of neurotransmission but also serves to replenish intracellular levels of transmitter for further release. Neurotransmitter transporters couple the inward movement of substrate to the movement of Na(+) down a concentration gradient and, in addition to their transport function, some carriers also display channel-like activities. Five Na(+)/K(+)-dependent glutamate transporter subtypes belong to the solute carrier 1 (SLC1) family and a second family, SLC6, encompasses the Na(+)/Cl(-)-dependent transporters for dopamine, 5-hydroxytryptamine (serotonin), noradrenaline, GABA and glycine. Recent advances, including high-resolution structures from both families, are now providing new insights into the molecular determinants that contribute to substrate translocation and ion channel activities. Other influential studies have explored how cellular regulatory mechanisms modulate transporter function, and how the different functions of the carrier shape the patterns of neurotransmitter signaling. This review focuses on recent studies of glutamate and monoamine transporters as prototypes of the two carrier families.
Similar articles
-
Neurotransmitter transporters: molecular function of important drug targets.Trends Pharmacol Sci. 2006 Jul;27(7):375-83. doi: 10.1016/j.tips.2006.05.003. Epub 2006 Jun 9. Trends Pharmacol Sci. 2006. PMID: 16762425 Review.
-
Molecular pharmacology of glutamate transporters, EAATs and VGLUTs.Brain Res Brain Res Rev. 2004 Jul;45(3):250-65. doi: 10.1016/j.brainresrev.2004.04.004. Brain Res Brain Res Rev. 2004. PMID: 15210307 Review.
-
Bound to be different: neurotransmitter transporters meet their bacterial cousins.Mol Interv. 2007 Dec;7(6):306-9. doi: 10.1124/mi.7.6.4. Mol Interv. 2007. PMID: 18199851 Review.
-
Ancestry of neuronal monoamine transporters in the Metazoa.J Exp Biol. 2006 Dec;209(Pt 24):4858-68. doi: 10.1242/jeb.02607. J Exp Biol. 2006. PMID: 17142674
-
Neurotransmitter transporters: new insights into structure, function and pharmacology.Rev Bras Biol. 1996 Dec;56 Su 1 Pt 1:5-19. Rev Bras Biol. 1996. PMID: 9394486 Review.
Cited by
-
The Structural Basis of the Activity Cliff in Modafinil-Based Dopamine Transporter Inhibitors.Biomolecules. 2024 Jun 17;14(6):713. doi: 10.3390/biom14060713. Biomolecules. 2024. PMID: 38927116 Free PMC article.
-
Reduction of EEG theta power and changes in motor activity in rats treated with ceftriaxone.PLoS One. 2012;7(3):e34139. doi: 10.1371/journal.pone.0034139. Epub 2012 Mar 30. PLoS One. 2012. PMID: 22479544 Free PMC article.
-
Neurotransmitters, receptors, and second messengers galore in 40 years.J Neurosci. 2009 Oct 14;29(41):12717-21. doi: 10.1523/JNEUROSCI.3670-09.2009. J Neurosci. 2009. PMID: 19828781 Free PMC article.
-
Social defeat: impact on fear extinction and amygdala-prefrontal cortical theta synchrony in 5-HTT deficient mice.PLoS One. 2011;6(7):e22600. doi: 10.1371/journal.pone.0022600. Epub 2011 Jul 27. PLoS One. 2011. PMID: 21818344 Free PMC article.
-
Inherited epithelial transporter disorders--an overview.J Inherit Metab Dis. 2008 Apr;31(2):178-87. doi: 10.1007/s10545-008-0861-6. Epub 2008 Apr 14. J Inherit Metab Dis. 2008. PMID: 18415698 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources